Shannon Rutherford, NP
Adult Health · Harlan, KYNPI 1548492952
Payments from drug & device makers
Across 46 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$202
- AbbVie$163
- Astellas Pharma US Inc$93
- Dexcom, Inc.$84
- Lilly USA, LLC$75
- Abbott$47
- plus $245 from 15 others
What the payments were for
- Food & beverage$81690%
- Education$9310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $202 |
| AbbVie | 9 | $163 |
| Astellas Pharma US Inc | 1 | $93 |
| Dexcom, Inc. | 2 | $84 |
| Lilly USA, LLC | 5 | $75 |
| Abbott | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Insulet Corporation | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Amgen | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Indivior Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| IBSA Pharma Inc. | 1 | $11 |
How this compares
$909 in reported general payments places this provider in the 60th percentile of 170 adult health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HumiraAdalimumab | 13 | $165,095 |
| VivitrolNaltrexone Microspheres | 69 | $109,229 |
| JanuviaSitagliptin Phosphate | 43 | $35,615 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 349 | $31,037 |
| OzempicSemaglutide | 32 | $30,215 |
| EliquisApixaban | 30 | $28,932 |
| JardianceEmpagliflozin | 20 | $28,286 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $23,555 |
| LinzessLinaclotide | 24 | $18,291 |
| FarxigaDapagliflozin Propanediol | 16 | $14,397 |
| EntrestoSacubitril/Valsartan | 25 | $13,572 |
| MounjaroTirzepatide | 12 | $12,532 |
| Humalog Kwikpen U-100Insulin Lispro | 29 | $9,308 |
| Ondansetron Hcl | 62 | $9,098 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $8,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira, Linzess, Restasis, Lumigan | $163 | $192,51462 claims |
| Alkermes, Inc.Vivitrol | $18 | $109,22969 claims |
| Novo NordiskOzempic | $202 | $30,21532 claims |
| NovartisEntresto | $17 | $13,57225 claims |
| Lilly USA, LLCMounjaro | $75 | $12,53212 claims |
| Indivior Inc.Suboxone | $13 | $8,13717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 170 adult health providers in Kentucky.
Other adult health in Harlan
- Carrie Clifford-BennettGeorgetown$730K
- Stephanie FlaspoehlerLouisville$174K
- Kimberly VesselsBrandenburg$58K
- Heidi GalloLouisville$15K
- Amy BakerPaducah$14K
- Joyce JohnsonElizabethtown$12K
- Karen EastridgeLouisville$10K
- Seon Hui BalistrereHopkinsville$8K
- Barbara CarpenterLouisville$8K
- Jennifer ThomasPaducah$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.